SCHEMBL9534756

SCHEMBL9534756

C#CC(=O)N1CCN([C]=O)CC1

nearest known ligand 0.45

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GPX4 P36969 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3378405 0.75
SCHEMBL4550633 0.74 CYP1A2 (0.52) GPX4
SCHEMBL24438361 0.73 ALDH1A1 (0.48) GPX4
SCHEMBL8722765 0.73 ALDH1A1 (0.31)
SCHEMBL8432009 0.73 ALDH1A1 (0.48) GPX4
SCHEMBL6969800 0.73 ALDH1A1 (0.31)
SCHEMBL1591122 0.71 HTR1A (0.39)
SCHEMBL1307068 0.71 CYP1A2 (0.54)
SCHEMBL209742 0.71
SCHEMBL9532761 0.70 GPX4 (0.39) GPX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0277836-B1 THIAZOLIDINONE DERIVATIVES, THEIR PREPARATION AND THEIR USE Sankyo Company Limited (JP) 1993-06-02 EP disclosed
US-5104888-A Anticholesterol or antidiabetic agents SANKYO COMPANY, LIMITED (JP) 1992-04-14 US disclosed
US-4873255-A REDUCE BLOOD GLUCOSE AND BLOOD LIPID LEVELS SANKYO COMPANY LIMITED (JP) 1989-10-10 US disclosed
EP-0277836-A1 Thiazolidinone derivatives, their preparation and their use Sankyo Company Limited (JP) 1988-08-10 EP disclosed